Comments
Commented by Stefan Feulner on October 10th, 2023 | 08:40 CEST
Exxon Mobil, Saturn Oil + Gas, Shell - Setback offers new opportunities
The run-up on the global oil markets was halted for the time being following a rally that had lasted since the end of June, with highs of around USD 96 per barrel for North Sea Brent. Thus, pessimism spread concerning falling demand from the US economy. For chart technicians, however, the current correction merely means a countermovement in the overriding upward trend. The Hamas attack on Israel over the weekend may have already ended this, potentially offering new entry opportunities at current levels.
Read
Commented by Nico Popp on October 10th, 2023 | 07:30 CEST
Good for the Climate - and the Returns: Nordex, Vestas, GoviEx
Climate protection is rightly booming. But what if renewable energy simply doesn't make financial sense, and private investors are hesitant to get involved? The wind power industry, in particular, has been under pressure for years. We explain what is holding back companies like Nordex, when their shares could make a comeback, and explore lesser-known alternatives in the field of climate protection. Let's get started!
Read
Commented by André Will-Laudien on October 10th, 2023 | 07:10 CEST
Hydrogen before the rebound! Nel, First Hydrogen and ThyssenKrupp Nucera in focus
The stock market environment is currently not characterized by a festive mood. Many conflicts and political uncertainties dominate the minds. Even hydrogen stocks have not been spared major price corrections for investors. However, investors with a healthy long-term focus should look a few years ahead. After all, climate change and alternative energies will have difficulty bypassing the hydrogen issue. Public initiatives will increase, if not today, then tomorrow. Even today, however, the entire sector is available for purchase at a high discount. First Hydrogen is very innovative, and there are good rebound opportunities for Nel and ThyssenKrupp. We do the math.
Read
Commented by Stefan Feulner on October 9th, 2023 | 07:10 CEST
Infineon, Manuka Resources, BYD - Analysts see significant potential
The reporting season for the third quarter of fiscal year 2023 is approaching and could herald a year-end rally on the stock markets despite challenging conditions with increasing geopolitical tensions and persistently high inflation. In recent days, companies have expressed optimism concerning the future course of business.
Read
Commented by Armin Schulz on October 9th, 2023 | 06:50 CEST
ThyssenKrupp, Almonty Industries, Rheinmetall - Good buying opportunities
Today, we are looking at three companies that offer good buying opportunities. For ThyssenKrupp, the recent positive news was that the unions are not demanding a 4-day workweek for the time being. Almonty Industries is benefiting from the fact that tungsten is being used in more and more new technologies. This includes the rising demand for tungsten in electric vehicle batteries. Rheinmetall could be an interesting buy candidate after the setback. Read the article to find out where the strengths of the three candidates lie.
Read
Commented by Stefan Feulner on October 6th, 2023 | 07:20 CEST
Nordex, dynaCERT, SMA Solar - Future Industries on Sale
Companies in the renewable energy sector have been in a sharp correction for months. Whether wind, hydrogen or solar, share price losses of over 50% for market leaders such as Plug Power or Nel Asa have not been an isolated case since the beginning of the year. Nevertheless, the future looks promising in these areas, as sharp price setbacks often represent unique long-term buying opportunities.
Read
Commented by Nico Popp on October 5th, 2023 | 09:10 CEST
Plain talk from the "Auto-Pope" - this changes everything! Mercedes-Benz, NIO, Power Nickel
Ferdinand Dudenhöffer heads the CAR Center Automotive Research in Duisburg and has been the go-to media expert for cars for decades. Over the years, Dudenhöfer has seen many trends come and go. In his latest guest commentary in Handelsblatt, Dudenhöffer did not mince his words and identified a new development that, regardless of the electrification of the industry, could determine success or failure - what new manufacturing means and how the upheaval could affect auto stocks. We provide an analysis.
Read
Commented by André Will-Laudien on October 5th, 2023 | 08:50 CEST
Hydrogen - further caution. Gold - strong buy! Nel, Plug and Nucera in the sell-off, consider increasing Globex Mining!
The year 2023 will go down in the history books as the anti-bull market for hydrogen stocks. Because of political declarations of intent, they were the most sought-after stocks on the stock market in 2019 and 2021. However, instead of public and private initiatives, hydrogen is becoming a specialized solution. Electrolysis, which is costly, makes sense where there is enough green energy and surplus available from the grid. In Europe, however, there is more of an energy problem, and expensive hydrogen cannot offer economic solutions. Investors are therefore rethinking and selling the still costly stocks. Mining and mining stocks have also fallen in 2023, but gold and strategic metals have an undeniable demand. Taking a look at Globex Mining could be worthwhile at this point. Here are some ideas for the active investor.
Read
Commented by Nico Popp on October 5th, 2023 | 08:35 CEST
Future investments that will soon ignite: Volkswagen, JinkoSolar, Defense Metals
Do you wish you had a crystal ball? What a question! Those who know the future could make great profit from it. But even without magical powers, one can succeed in consistently aligning your portfolio with the future. We explain how this works and what investors need to watch out for. In addition, we present three companies with great future potential and highlight when investments could be worthwhile and when investors would be better to wait and see.
Read
Commented by Fabian Lorenz on October 5th, 2023 | 07:10 CEST
Buy biotech stocks now? BioNTech, Morphosys and Cardiol Therapeutics in check
In times of high interest rates, the wheat is separated from the chaff, even in the biotech sector. After all, young research-based companies, in particular, have a high demand for capital. But at the moment, all companies are being lumped together. This opens up clear buying opportunities because some have full coffers. BioNTech belongs to this group. Thanks to the COVID-19 vaccine, research is fully financed. The same goes for Cardiol Therapeutics. The share of the Canadians is one of the summer's high flyers, and the recent price setback offers an entry opportunity. The analysts' price target is over 300% above the current level. And what do analysts say about the German biotech veteran Morphosys? Goldman Sachs has tripled its price target.
Read